Provided by Tiger Fintech (Singapore) Pte. Ltd.

United Therapeutics

317.87
+1.960.62%
Post-market: 315.10-2.7700-0.87%17:00 EDT
Volume:435.98K
Turnover:139.21M
Market Cap:14.28B
PE:12.90
High:323.99
Open:313.93
Low:313.93
Close:315.91
Loading ...

BRIEF-United Therapeutics Gets FDA Clearance for uKidney Xenotransplantation Clinical Trial

Reuters
·
03 Feb

United Therapeutics Corporation Announces FDA Clearance of Its Investigational New Drug Application for the Ukidney Xenotransplantation Clinical Trial

THOMSON REUTERS
·
03 Feb

United Therapeutics Corp - First Xenotransplant Expected Around Mid-Year 2025

THOMSON REUTERS
·
03 Feb

United Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial

Business Wire
·
03 Feb

Merck Halts Second PAH Drug Study Early on Strong Efficacy Results

Zacks
·
01 Feb

Drug Companies Raise Prices on More Than 800 Drugs in January -- Update

Dow Jones
·
29 Jan

BTIG Reaffirms Their Hold Rating on United Therapeutics (UTHR)

TIPRANKS
·
24 Jan

United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the Pulmonary Vascular Research Institute 2025 Annual Congress

Business Wire
·
21 Jan

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Zacks
·
20 Jan

Top Stock Reports for Tesla, Bank of America & Alibaba

Zacks
·
14 Jan

United Therapeutics to Present at J.P. Morgan Conference

TIPRANKS
·
13 Jan

Here's Why United Therapeutics (UTHR) is a Strong Value Stock

Zacks
·
09 Jan

Are Medical Stocks Lagging United Therapeutics (UTHR) This Year?

Zacks
·
09 Jan

UTHR vs. STVN: Which Stock Is the Better Value Option?

Zacks
·
09 Jan

United Therapeutics Is Maintained at Buy by UBS

Dow Jones
·
08 Jan

UBS Raises Price Target on United Therapeutics to $475 From $415, Keeps Buy Rating

MT Newswires Live
·
08 Jan